Pasithea Therapeutics Corp. (KTTA)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 7.55M |
| Enterprise Value | -8.70M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 42.15 |
| Price/Book (mrq) | 0.32 |
| Enterprise Value/Revenue | -23.94 |
| Enterprise Value/EBITDA | 0.57 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.88 |
| 52-Week Change 3 | 3.43% |
| S&P500 52-Week Change 3 | 21.08% |
| 52 Week High 3 | 17.40 |
| 52 Week Low 3 | 5.26 |
| 50-Day Moving Average 3 | 7.38 |
| 200-Day Moving Average 3 | 8.39 |
Share Statistics
| Avg Vol (3 month) 3 | 3.85k |
| Avg Vol (10 day) 3 | 980 |
| Shares Outstanding 5 | 1.04M |
| Implied Shares Outstanding 6 | 1.04M |
| Float 8 | 748.76k |
| % Held by Insiders 1 | 140.58% |
| % Held by Institutions 1 | 23.87% |
| Shares Short (Apr 15, 2024) 4 | 9.95k |
| Short Ratio (Apr 15, 2024) 4 | 3.89 |
| Short % of Float (Apr 15, 2024) 4 | 1.27% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.95% |
| Shares Short (prior month Mar 15, 2024) 4 | 8.44k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Jan 02, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -28.02% |
| Return on Equity (ttm) | -47.07% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -15.33M |
| Net Income Avi to Common (ttm) | -15.51M |
| Diluted EPS (ttm) | -12.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.33M |
| Total Cash Per Share (mrq) | 15.67 |
| Total Debt (mrq) | 81.68k |
| Total Debt/Equity (mrq) | 0.35% |
| Current Ratio (mrq) | 6.34 |
| Book Value Per Share (mrq) | 22.46 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13.43M |
| Levered Free Cash Flow (ttm) | -7.32M |
© 2024 Yahoo. All rights reserved.